<p>Dr. Peter Jones sits down with Dr. Charis Himeda to discuss her invention of CRISPR-inhibition for FSHD, some of the bumps along the way, and its ultimate therapeutic potential and constraints.  In addition, other CRISPR technology that is being developed for FSHD is discussed.</p>

Dr. Peter Jones sits down with Dr. Charis Himeda to discuss her invention of CRISPR-inhibition for FSHD, some of the bumps along the way, and its ultimate therapeutic potential and constraints. In addition, other CRISPR technology that is being developed for FSHD is discussed.

<p>Dr. Peter Jones sits down with Dr. Charis Himeda to discuss her invention of CRISPR-inhibition for FSHD, some of the bumps along the way, and its ultimate therapeutic potential and constraints. &nbsp;In addition, other CRISPR technology that is being developed for FSHD is discussed.</p>

CRISPR technology for FSHD with Dr. Charis Himeda

MyFSHD is about education and personal empowerment for the worldwide facioscapulohumeral muscular dystrophy (FSHD) community. Here we have discussions and commentary hosted by FSHD researcher Peter Jones, PhD, on many things of interest to the FSHD community. Learn about the science behind the different FSHD therapeutic approaches, FSHD pathology, family genetics and FSHD diagnostics. We will discuss upcoming clinical trials and what to look forward to. You will get to understand how you can be better prepared, become involved, and help contribute to defeating FSHD once and for all.

Share CRISPR technology for FSHD with Dr. Charis Himeda

Sign up to save your podcasts

CRISPR technology for FSHD with Dr. Charis Himeda

CRISPR technology for FSHD with Dr. Charis Himeda